IDT Biologika
Pharmaceutical ManufacturingSaxony-anhalt, Germany501-1000 Employees
IDT Biologika is a pharmaceutical manufacturing contract development and manufacturing organization (CDMO) based in Germany, with headquarters in Dessau-Rosslau and Magdeburg, Saxony-Anhalt, and a North American facility in Rockville, Maryland. The company provides end-to-end services for viral vaccines, viral vectors for cell and gene therapeutics, and other biologics, covering process development, clinical and commercial-scale drug substance production, aseptic filling and lyophilization, labeling, packaging, storage, and quality control and analytical services. IDT Biologika operates under regulatory standards including FDA, EMA, and ANVISA, and maintains capabilities for large-scale campaign production and end-to-end manufacturing. The company has about 501-1000 employees, and maintains a European and North American footprint with integrated facilities in Germany and the United States. In 2024, SK Bioscience acquired a 60% stake in IDT Biologika GmbH for about $244 million.